Stepan
- Market cap
- 1.39B
- P/E (TTM)i
- -511.00
- P/Bi
- 1.15
- EPSi
- 2.05
- Div yieldi
- 2.56%
- 52W posi
- 80%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 89.10% -0.03pp
- Institutions
- 269
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 10 sells
| Name | Role | Stake |
|---|---|---|
| F. Stepan | Non-Executive Chairperson | 2.82% |
| Richard Stepan | Vice President & General Manager of Polymers | 2.09% |
| Sean Moriarty | Former VP & GM of Polymers | 0.09% |
| Luis Rojo | Vice President | 0.09% |
| Joaquin Delgado | Independent Director | 0.08% |
| Randall Dearth | Independent Director | 0.07% |
| Jan Reed | Independent Director | 0.07% |
| Matthew Eaken | Officer | 0.05% |
| David Kabbes | Vice President | 0.05% |
| Edward Wehmer | Lead Independent Director | 0.05% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-25 | Shawn Lisle | -- | Derivative Exercise and Sale | -339 | $62.35 |
| 2026-08-25 | Shawn Lisle | -- | Derivative Exercise and Retained | +815 | $62.35 |
| 2026-08-09 | Ruben Velasquez | Chief Financial Officer | Derivative Exercise and Sale | -398 | $64.68 |
| 2026-08-09 | Ruben Velasquez | Chief Financial Officer | Derivative Exercise and Retained | +960 | $64.68 |
| 2026-08-03 | Matthew Eaken | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-05-10 | Robin Weitkamp | -- | Derivative Exercise and Sale | -50 | $52.58 |
| 2026-05-10 | Robin Weitkamp | -- | Derivative Exercise and Retained | +40 | $52.58 |
| 2026-05-07 | Jan Reed | Independent Director | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | F. Stepan | Non-Executive Chairperson | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | Corning Painter | Director | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | Joaquin Delgado | Independent Director | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | Randall Dearth | Independent Director | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | Susan Lewis | Director | Other Acquisition | +2,566 | $52.61 |
| 2026-05-07 | Lorinda Burgess | Independent Director | Other Acquisition | +2,566 | $52.61 |
| 2026-04-30 | Robert Haire | Executive Vice President of Supply Chain | Derivative Exercise and Sale | -162 | $50.33 |
| 2026-04-30 | Robert Haire | Executive Vice President of Supply Chain | Derivative Exercise and Retained | +388 | $50.33 |
| 2026-04-12 | Robin Weitkamp | -- | Other Derivative Acquisition | +1,429 | -- |
| 2026-04-12 | Robin Weitkamp | -- | Other Derivative Acquisition | +2,859 | -- |
| 2026-04-12 | Robin Weitkamp | -- | Other Derivative Acquisition | +4,030 | $52.46 |
| 2026-04-12 | Adriano Afonso | VP of Surfactants & GM of North America - Surfactants | Other Derivative Acquisition | +1,310 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:31:08 · For reference only, not investment advice and not tailored to your situation.